The global cervical cancer diagnostic tests market size is expected to reach USD 9,180.63 Million in 2030 and register a revenue CAGR of 5.0% over the forecast period, according to latest report by Reports and Data. Steady revenue growth of the market can be attributed to several factors, such as growing awareness about cervical cancer screening and technological advancements in diagnosis. However, high costs associated with cervical cancer diagnostic tests may hamper market revenue growth over the forecast period.

Cervical cancer is the fourth-most common cancer and cause of cancer deaths in women worldwide. In 2018, 570,000 cases of cervical cancer were recorded, with over 300,000 deaths, and it accounts for around 8% of both total cancer cases and total cancer deaths in women. Approximately, 80% of cervical cancer occurs in developing countries, as per data from WHO, and it is the most frequently detected cancer during pregnancy. Hence, early diagnosis of cervical cancer is essential to initiate early treatment and thus, reduce mortality rates. Various testing procedures are available for the diagnosis of cervical cancer, but the most accessible and easy testing method is the pap smear test.

The diagnostic test used for cervical cancer is a simple process in which cells are collected from a woman’s cervix and checked for abnormalities, if any. Advancements in technologies have enabled detection of cervical cancer at a fast rate, even at homes, with better accuracy. Governments worldwide are promoting testing devices on a mass scale, especially to women above 30 years of age, in order to help them to undergo such diagnostic tests frequently to identify the disease at an early stage.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1438



Some Key Factors Contributing to the Global Pharma & Healthcare Market Growth

Unprecedented revenue growth of the global pharma & healthcare industry is attributed to factors such as rising prevalence of chronic and acute diseases worldwide, increasing geriatric population, rising awareness of health & wellness among consumers, and growing demand for more advanced healthcare services. Increasing demand for advanced drugs and therapeutics, growing availability of next-generation diagnostics and treatment options – especially in developing countries like India and China – rise in R&D activities and clinical trials in the pharmaceutical and biotechnology sectors, increasing public and private investments in healthcare research projects, and rising consumer expenditure on healthcare are among the other significant factors contributing to the industry revenue growth.

Some Key Highlights from the Report

  • Among therapy segments, chemotherapy segment accounted for largest revenue share in 2021. Chemotherapy is a drug treatment that uses powerful chemicals to destroy fast growing cells in the body, and is most often used to treat cancer. It is used in different ways to treat cancer patients, and is quite effective, as it doesn’t require any supplementary treatment to cure cancer. Additionally, it can relieve signs and symptoms of cancer as well. 
  • Among therapy segments, the radiation therapy segment is expected to register a faster revenue CAGR during the forecast period, due to increasing adoption of radiation therapy, as it can completely eliminate cancer cells from the body by using high energy X-rays. The therapy can be used as an alternative to surgical interventions in the early stages of cancer. The specific therapy given to patients of cervical cancer depends on several factors, such as health of the woman, stage of the cancer, tolerance capacity, side effects of the therapy, and overall fitness of the patient. Several cancer treatments or therapies are given in combination with internal radiation therapy to achieve maximum results, which is expected to drive segment revenue growth.
  • cervical cancer diagnostic tests market in North America accounted for largest revenue share in 2021, due to technological developments in the healthcare industry. Presence of an advanced medical sector in the region is playing a pivotal role in facilitating extensive research & development activities for innovative product launches. Rising investments in allied industries, such as pharmaceuticals and biotechnology, are contributing significantly to the growth of this market. Moreover, several key market players have their headquarters in countries in the region, which is further driving overall market growth. Additionally, countries such as the U.S. and Canada have high prevalence of cervical cancer, and so there is increasing demand for novel and effective diagnostic and therapeutic modalities in the region, which is expected to drive market revenue growth in North America.
  • In November 2021, Hologic Inc. completed the acquisition of Bolder Surgical, a privately held, U.S.–based company that provides advanced energy vessel sealing surgical devices. This acquisition focuses on expanding Hologic’s growing laparoscopic portfolio and underscores their commitments to women’s health. Hologic, Inc. is an innovative medical technology company focusing primarily on improving women’s health and well-being through early detection and treatment of diseases.

Top Players in the Global Cervical Cancer Diagnostic Market:

Abbott Laboratories Ltd., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Guided Therapeutics Inc., Hologic Inc., Qiagen N.V., Quest Diagnostics Inc., CooperSurgical Inc., and Arbor Vita Corporation.

The coronavirus pandemic has had a drastic impact on the global healthcare industry, with rising cases of COVID-19 worldwide, substantially growing hospital admission and readmission rates, and rising demand for telehealth and telemedicine services for remote patient monitoring. Furthermore, rising focus on development of rapid COVID-19 diagnostics such as the RT-PCR test kits, increased government funding for vaccine development, stringent regulatory norms and protocols for COVID-19 safety, and increasing sales of COVID-19 safety equipment, such as N-95 masks, face shields, PPE kits, and hand sanitizers, have driven the global pharma & healthcare industry revenue growth over the recent past.  

To know more about the report @ https://www.reportsanddata.com/report-detail/cervical-cancer-diagnostic-market

Cervical Cancer Diagnostic Market Segmentation:

Test Type Outlook (Revenue, USD Billion; 2019–2030)

  • Pap Smear Tests
  • Colposcopy
  • HPV Testing
  • Biopsy and Endocervical curettage
  • Others

End-use Outlook (Revenue, USD Billion; 2019–2030)

  • Hospitals and Clinics
  • Laboratories
  • Diagnosing Centers
  • Others

Therapy Outlook (Revenue, USD Billion; 2019–2030)

  • Surgery
  • Radiation Therapy
  • Chemotherapy
  • Targeted Therapy

Global Cervical Cancer Diagnostic Market Report: Regional Segmentation

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1438

Frequently Asked Questions Answered in the Report:

  • What is the estimated revenue growth rate of the global Cervical Cancer Diagnostic market over the forecast period?
  • What are the major factors driving the global market revenue growth?
  • Which are the leading manufacturers and suppliers in the global Cervical Cancer Diagnostic market?
  • Which regional market is expected to lead in terms of revenue share in the global Cervical Cancer Diagnostic market over the forecast years?
  • What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis of the market?

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.

Read More Reports:

Electrocardiograph Market: https://www.reportsanddata.com/report-detail/electrocardiograph-market

Artificial Ventilators and Anesthesia Masks Market: https://www.reportsanddata.com/report-detail/artificial-ventilators-and-anesthesia-masks-market

Medical Membranes Market: https://www.reportsanddata.com/report-detail/medical-membranes-market

Health Information Exchange Market: https://www.reportsanddata.com/report-detail/health-information-exchange-market

Hedgehog Pathway Inhibitors Market: https://www.reportsanddata.com/report-detail/hedgehog-pathway-inhibitors-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problem provide our clients with the ability to secure an edge over their respective competitors.